Overview

PROMMO Trial: Oral Misoprostol vs IV Oxytocin

Status:
Recruiting

Trial end date:
2022-02-01

Target enrollment:

Participant gender:

Summary

This is a prospective, randomized trial looking at the ideal method of labor induction for women with prelabor rupture of membranes and an unfavorable cervical Bishop score. The study will compare oral misoprostol and intravenous oxytocin.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Wisconsin, Madison

Treatments:

Misoprostol
Oxytocin